![]() ![]() Roche®, Ventana®, Benchmark® XT, and Benchmark® Ultra are registered trademarks of Roche. Item Description Identification EDMA 760-2708 05268176001 ACTH Rabbit Polyclonal Antibody 13.07.01.09 760-2601 05267161001 Actin, Muscle Specific (HHF35) Mouse Monoclonal Antibody 13.07.01.09 760-2833 05268303001 Actin, Smooth Muscle (1A4) Mouse Monoclonal Antibody 13.07.01. UltraLine antibodies are developed solely by Biocare Medical and do not imply approval or endorsement of Biocare’s antibodies by Roche® or VENTANA®.īiocare and Roche/Ventana are not affiliated, associated or related in any way. ![]() Free White Paper: Which Biocare Antibodies Are Right For Your Roche or Ventana Instrument? View all Ultraline Antibodies To learn more about our automated spatial RNA & protein Co-Detection workflow on the Roche DISCOVERY ULTRA Platform watch the on-demand. To learn more about optimizing antibodies on your Roche or Ventana BenchMark Ultra, download the white paper below. ![]() Monoclonal Primary Antibody (catalog 790-4430 Ventana Medical Systems). The UltraLine from Biocare covers a wide range of antibodies used in all tissue types including p63 and ERG for prostate, MSI panel for colon, and CK5/14 + p63 + CK7/18 double stain for breast tissue. The ultraView DAB IHC Detection kit (Catalog 760-500 Ventana) with reagent. To aid in optimization, protocols utilizing ultraView or OptiView detection are specified on the corresponding antibody datasheet. This line of antibodies, called “UltraLine Antibodies”, is optimized utilizing Biocare’s ISO-certified antibody development process on the Roche and Ventana Benchmark Ultra® slide-staining system to ensure appropriate staining intensity. (790-4497) E-cadherin (36) Mouse Monoclonal Primary Antibody, VENTANA Supplier. In the United States, Japan and Canada, MabThera is marketed as Rituxan.Biocare Medical has created a line of prediluted antibodies specially formulated for use on Roche and Ventana platforms. In Europe, MabThera has recently been approved in paediatric indications in GPA/MPA patients for induction of remission and previously untreated B-NHL, in combination with chemotherapy. Roche VENTANA CONFIRM anti-Estrogen Receptor (ER) (SP1) Rabbit Monoclonal Primary Antibody. The UltraLine from Biocare covers a wide range of antibodies used in all tissue types including p63 and ERG for prostate, MSI panel for colon, and CK5/14 + p63 + CK7/18 double stain for breast tissue. MabThera is also approved for the treatment of adults in auto-immune diseases: severe active rheumatoid arthritis, pemphigus vulgaris and severe active granulomatosis with polyangiitis and microscopic polyangiitis (GPA/MPA). Ventana Medical Systems Inc, 1910 E Innovation Park Dr, Tucson AZ 85755-1962 Manufacturer Parent Company (2017). In the United States, Europe and in other countries, MabThera is approved for the treatment of adults with the following blood cancers: previously untreated and relapsed/refractory follicular lymphoma, previously untreated diffuse large B-cell lymphoma, and previously untreated and relapsed/refractory chronic lymphocytic leukaemia. 15.2 () Antibodies Low Risk Ventana Catalog No. Bioz Stars score: 86/100, based on 1 PubMed citations. MabThera attacks these cells both directly and together with the body’s immune system. 124 antibody diluent buffer ventana medical systems124 Antibody Diluent Buffer Ventana Medical Systems, supplied by Roche, used in various techniques. These cells are central to many blood cancers, including common forms of lymphoma and leukaemia. MabThera was the first therapeutic monoclonal antibody to target cells that have the CD20 marker on their surface. Solutions Pharma Products See all Pharma Products Rothermel L, Sabesan A, Stephens D, Chandran S, Paria B, Srivastava A, et al.Identification of an Immunogenic Subset of Metastatic Uveal Melanoma. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |